missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human UBL4A (aa 23-154) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (89%), Rat (89%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-51974 (PA5-51974. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
UBL4A is a component of the BAT3 complex, a multiprotein complex involved in the post-translational delivery of tail-anchored (TA) membrane proteins to the endoplasmic reticulum membrane. UBL4A is the TA membrane proteins, also named type II transmembrane proteins, contain a single C-terminal transmembrane region. The complex acts by facilitating TA proteins capture by ASNA1/TRC40: it is recruited to ribosomes synthesizing membrane proteins, interacts with the transmembrane region of newly released TA proteins, and transfers them to ASNA1/TRC40 for targeting.
Specifications
Specifications
| Accession Number | P11441 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 8266 |
| Name | Human UBL4A (aa 23-154) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | D x 254 E; DXHXS254E; DXS254E; DXS254Eh; G6PD; GDX; GET5; housekeeping protein DXS254E; hypothetical protein LOC504533; MDY2; RGD1563983; TMA24; ubiquitin like 4 A; ubiquitin-like 4; ubiquitin-like 4 A; ubiquitin-like protein 4 A; Ubiquitin-like protein GDX; UBL4; UBL4A |
| Common Name | UBL4A |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction